Liu, Y., Liu, Y., Zhao, X., Zhao, X., Wang, X., Wang, X., . . . Zhou, Q. Adverse events of hepatic anti-fibrotic agents in phase 3 and above clinical trials: A descriptive analysis of the WHO-VigiAccess database. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLiu, Yuwei, Yuwei Liu, Xu Zhao, Xu Zhao, Xinrui Wang, Xinrui Wang, Qiang Zhou, and Qiang Zhou. Adverse Events of Hepatic Anti-fibrotic Agents in Phase 3 and Above Clinical Trials: A Descriptive Analysis of the WHO-VigiAccess Database. Frontiers Media S.A.
MLA (9th ed.) CitationLiu, Yuwei, et al. Adverse Events of Hepatic Anti-fibrotic Agents in Phase 3 and Above Clinical Trials: A Descriptive Analysis of the WHO-VigiAccess Database. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.